Commentary
Video
The director of Integrative Neurosciences at Allegheny Health Network talked about integrative neurology, personalized medicine, and emerging diagnostic tools that enhance patient-centered care. [WATCH TIME: 5 minutes]
WATCH TIME: 5 minutes
“If we can reach out to patients before they have symptoms, rather than ‘chasing our tails’ and treating them after the fact, that will make a significant difference.”
As neurology progresses in 2025, the field is on the brink of transformative advancements that could significantly improve patient care. The integration of emerging technologies and therapies is offering new hope for individuals with neurological conditions, expanding treatment options and enhancing outcomes. With innovations ranging from cutting-edge medical devices to holistic treatment strategies, clinicians are eager to embrace the future of neurological care.
Simultaneously, a growing understanding of neurological disorders is driving more precise and individualized treatment approaches. Conditions such as movement disorders, migraine, epilepsy, neuromuscular diseases, sleep disorders, and multiple sclerosis are being studied at a more molecular level, allowing for more tailored and effective management strategies. The combination of novel therapies, technological advancements, and a deeper comprehension of these diseases has created new possibilities for both healthcare providers and patients.
In a recent interview with NeurologyLive®, Sushma Kola, MD, a movement disorder specialist and director of Integrative Neurosciences at Allegheny Health Network, shared her perspective on key innovations expected to shape the field in 2025. She discussed the impact of new diagnostic tools, the expansion of personalized medicine, and the increasing role of wearable technology and biomarkers in clinical practice. Additionally, she highlighted promising developments in movement disorder research and underscored the importance of a holistic, patient-centered approach to care.